Cutaneous sarcoidosis – Diagnostics – Overview of Information and Clinical Research

Cutaneous sarcoidosis affects the skin in up to one third of people with sarcoidosis, a disease that causes tiny clusters of inflamed cells to form in various organs. Because skin lesions can look very different from one case to another, doctors often call cutaneous sarcoidosis one of the “great imitators” in dermatology. Recognizing these skin changes is important because they offer a visible clue to diagnosis and provide an easily accessible place to take tissue samples for examination.

Introduction: Who Should Undergo Diagnostics

If you notice unusual changes on your skin that do not go away, it is advisable to seek medical evaluation. Cutaneous sarcoidosis can appear in many forms, including bumps, plaques, tender nodules, or changes in old scars, and these signs may appear before, during, or after other organs become involved.^[1] Early recognition of these skin changes can help doctors identify systemic sarcoidosis and start monitoring or treatment if needed.

People who already know they have sarcoidosis in other organs, such as the lungs, should also pay attention to any new skin symptoms. Since cutaneous involvement occurs in 20 to 35 percent of patients with systemic sarcoidosis, your doctor may want to examine your skin regularly as part of your ongoing care.^[1] Even if you feel well otherwise, visible skin lesions can provide valuable information about how active the disease is in your body.

Anyone experiencing general symptoms such as extreme tiredness, slight fever, swollen lymph nodes, weight loss, or joint pain and swelling should consider seeking medical advice, especially if these symptoms appear together with skin changes.^[5] Sometimes sarcoidosis does not cause any symptoms at all, and the disease may be discovered only when a chest X-ray is done for another reason. However, when skin lesions are present, they serve as an important signal that should not be ignored.

⚠️ Important

Sarcoidosis can affect many different organs, so even if your skin symptoms seem mild, it is important to have a complete medical evaluation. Your doctor will want to check whether other parts of your body, such as your lungs, eyes, or heart, are also involved. Early detection of organ involvement can help prevent complications and guide appropriate monitoring or treatment decisions.

Classic Diagnostic Methods

Diagnosing cutaneous sarcoidosis can be challenging because there is no single test that can definitively prove the disease. Instead, doctors rely on a combination of approaches: a compatible clinical picture, examination of tissue under a microscope showing specific changes, and ruling out other possible causes, especially infections.^[1] This process requires careful attention to detail and sometimes several steps to reach a confident diagnosis.

Physical Examination and Medical History

Your healthcare professional will begin by doing a thorough physical exam and asking about your symptoms and possible risk factors. During the exam, the doctor will listen to your heart and lungs, check your lymph nodes for swelling, and carefully look at any skin lesions you may have.^[11] The appearance, location, color, and texture of your skin changes all provide important clues. Understanding your medical history helps the doctor consider whether other conditions might explain your symptoms.

Skin Biopsy

A skin biopsy is typically the most important diagnostic tool for cutaneous sarcoidosis. Because skin lesions are visible and easily accessible, they provide a convenient source of tissue for examination. The doctor uses a punch or incisional wedge biopsy technique to obtain a sample that includes the deeper layer of skin called the dermis.^[1] This procedure is usually done in the doctor’s office with local numbing medicine, so you should not feel pain during the sample collection.

Once the tissue sample is obtained, it is sent to a laboratory where a specialist examines it under a microscope. In cutaneous sarcoidosis, the pathologist looks for distinctive features called noncaseating granulomas. These are tiny clusters of immune cells that have gathered together but do not show the cheese-like appearance (called caseation) seen in some infections like tuberculosis.^[1] Finding these granulomas is a key step in making the diagnosis, but it is not the end of the process.

Because other conditions, including infections, can also cause granulomas, the tissue sample may need to be cultured to rule out infectious causes. This means growing any bacteria or fungi that might be present in the sample to make sure they are not responsible for the skin changes.^[1] Only after infections and other possible causes have been excluded can the diagnosis of sarcoidosis be confirmed.

Classification of Skin Lesions

Doctors divide cutaneous sarcoidosis lesions into two main types: nonspecific and specific. Nonspecific lesions occur in association with systemic sarcoidosis, but when biopsied, they do not show granulomas. The most common nonspecific lesion is erythema nodosum, which appears as extremely tender, red nodules under the skin, often on the front of the lower legs.^[1] This type of reaction can be triggered by many different causes, including medications, infections, and inflammatory diseases, not just sarcoidosis.

Specific lesions are those that show noncaseating granulomas on biopsy. Despite having the same microscopic appearance, these lesions can look very different on the skin. The term “specific” can be misleading because the clinical appearance is usually not specific to sarcoidosis alone, and the correct diagnosis often depends on the biopsy results.^[1] Common types of specific lesions include papules (small raised bumps), plaques (larger flat or slightly raised patches), lupus pernio (a distinctive chronic form affecting the nose and cheeks), and changes in old scars.

Tests to Assess Organ Involvement

Once cutaneous sarcoidosis is suspected or confirmed, your doctor will want to check whether the disease has affected other parts of your body. These tests help rule out other conditions and show which organ systems may be involved. You may have blood and urine tests to check your overall health and how well your kidneys and liver are working.^[11] These simple tests provide baseline information about your body’s function.

A chest X-ray is commonly ordered to look at your lungs and heart, as the lungs are the most frequently affected organs in sarcoidosis. Some people may need a more detailed computed tomography (CT) scan of the chest to get a clearer picture of the lungs.^[11] If you have respiratory symptoms, lung function tests (also called pulmonary function tests) may be done to measure how much air you can breathe in and out and how well oxygen is getting into your blood.

An electrocardiogram (ECG or EKG) and cardiac ultrasound may be performed to check for heart problems and look at your heart’s health, since cardiac involvement can be serious.^[11] An eye exam is also important to check for vision problems that sarcoidosis may cause. If your doctor suspects that sarcoidosis may be affecting your heart or central nervous system, you might need additional imaging such as a positron emission tomography (PET) scan or magnetic resonance imaging (MRI).

Distinguishing Sarcoidosis from Other Conditions

Because cutaneous sarcoidosis can mimic many other skin diseases, careful evaluation is needed to tell them apart. Papules of sarcoidosis might be confused with granulomatous rosacea, acne, or benign skin tumors. Plaques could look like psoriasis, lichen planus, eczema, discoid lupus, or even skin lymphoma. Erythema nodosum might be mistaken for cellulitis or other forms of inflammation under the skin.^[1] The biopsy results, combined with the overall clinical picture and exclusion of infections, help doctors make the correct diagnosis.

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for cutaneous sarcoidosis, you will likely undergo additional diagnostic tests beyond those used for standard diagnosis. Clinical trials have specific entry criteria to ensure that participants have the disease characteristics being studied and are safe to receive the investigational treatment. These qualification requirements help researchers obtain reliable results and protect participants from unnecessary risks.

Baseline tissue confirmation is typically required, meaning you will need a skin biopsy showing noncaseating granulomas to prove you have cutaneous sarcoidosis. The biopsy must also rule out infections and other causes of granulomas. Trials may require that this biopsy be performed within a certain timeframe before enrollment to ensure the diagnosis is current and accurate.

Comprehensive organ function testing is standard for clinical trial qualification. This includes blood tests to check your kidney and liver function, complete blood count, and tests for infections that might affect your eligibility or safety during the trial.^[11] These baseline values help researchers monitor any changes that occur during treatment and ensure that your body can safely process the study medication.

Imaging studies are often required to document the extent of disease. A chest X-ray or CT scan may be needed to evaluate lung involvement, even if you have no respiratory symptoms. Depending on the trial, you might also need an ECG or echocardiogram to assess heart function, since some treatments can affect the heart.^[11] These tests create a complete picture of your disease at the start of the trial, which can be compared to later results to measure treatment effects.

⚠️ Important

Clinical trials may have strict eligibility criteria based on disease severity, extent of organ involvement, previous treatments, and other health conditions. You might be excluded if you have certain infections, are pregnant, have severe organ damage, or are taking medications that could interfere with the study treatment. Discussing these requirements with your doctor can help you understand whether a specific trial might be appropriate for you.

Documentation of disease activity and severity is important for trial enrollment. Researchers may use standardized tools to measure the size, number, and appearance of your skin lesions. Photography is often used to document lesions before, during, and after treatment so that changes can be objectively assessed. You may also be asked to complete questionnaires about how your symptoms affect your daily life and quality of life.

Some trials require evidence that you have tried and not responded adequately to standard treatments before you can enroll. This might mean documenting that you have used topical or systemic medications without sufficient improvement. Having complete medical records of your previous treatments, including doses and duration, helps the research team determine your eligibility.

Specialized tests may be required depending on the specific trial. For example, if the trial is studying a medication that affects the immune system, you might need tests to evaluate your immune function. If the treatment targets a specific biological pathway, genetic or molecular testing might be needed to confirm that your disease involves that pathway. These specialized requirements vary widely between trials and depend on the nature of the intervention being studied.

Safety monitoring during clinical trials involves repeated diagnostic tests at scheduled intervals. You will likely have regular blood tests, physical examinations, and assessments of your skin lesions throughout the trial period. These ongoing evaluations help researchers detect any side effects early and measure how well the treatment is working. Understanding that clinical trial participation requires this level of commitment can help you decide whether enrollment is right for you.

Prognosis and Survival Rate

Prognosis

The course of sarcoidosis varies greatly among individuals. The disease can be mild, and symptoms may go away within a few years, even without treatment. Sometimes sarcoidosis slowly gets worse over the years and can cause permanent organ damage. The severity of the disease can vary by race and ethnicity.^[16] Many patients will not have long-term effects from sarcoidosis, while 5 to 10 percent of all patients will suffer from what is called advanced, chronic, or progressive sarcoidosis.

If your cutaneous sarcoidosis goes into remission, meaning the symptoms disappear, your doctor may carefully stop your medicines. However, you will still need to watch for a flare, which is when symptoms return. Most flares happen within six months of stopping treatment. The longer you go without symptoms, the less likely you are to have a flare.^[17] Predicting flares can be difficult, and each person’s experience with the disease is unique.

The type of skin lesions you have can provide some prognostic information. Erythema nodosum, when it appears as part of a condition called Lofgren’s syndrome (which includes erythema nodosum, bilateral hilar lymphadenopathy, and joint pain), often indicates an acute presentation of systemic sarcoidosis that may have a better prognosis.^[1] In contrast, certain chronic skin lesions like lupus pernio may be associated with more persistent disease. Your doctor will consider all aspects of your condition when discussing what to expect.

Survival rate

While specific survival statistics for cutaneous sarcoidosis alone are not well established, it is important to understand that sarcoidosis overall is usually not immediately life-threatening. However, cardiac and pulmonary involvement are the most common causes of death in patients with systemic sarcoidosis.^[6] This is why comprehensive evaluation of organ involvement is so important, even when the disease primarily affects the skin.

Most people with sarcoidosis, including those with skin involvement, can expect to live normal or near-normal lifespans with appropriate monitoring and treatment. The key is regular follow-up with your healthcare team to detect any progression of disease or development of complications in other organs. Early identification and management of organ involvement can significantly improve outcomes and quality of life.

#1 Clinical Trials Search in Europe